USPTO serial 99438872
INVITRIS
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- SCHOEN,LINDSEY O
- Law office
- TMO LAW OFFICE 130
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INVITRIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Planegg-Martinsried, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Keith A. Weltsch
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.300 Suite400 Garden City PlazaGarden City, NY 11530Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-microbial preparations for controlling biofilms and inhibition of bacteria; Anti- bacterial preparations, namely, sprays, creams and devices being containers for intravenous injection, namely, IV bags, infusion bottles, vials, ampoules, and prefilled syringes, sold filled with anti-bacterial pharmaceuticals; Anti-bacterial pharmaceuticals; Medicine for the prevention and treatment of infectious diseases being human or animal additives in the nature of dietary supplements for medical purposes; Food supplements for veterinary use; bacteriophages being pharmaceutical, medical, and veterinary preparations for prevention and treatment of bacteria-based diseases and disorders; Antibiotics; Anti-infectives; Preparations for microbiome health in the nature of probiotic preparations for medical use | ACTIVE | — |
| 040 | Custom biomanufacturing in the fields of pharmaceuticals, vaccines, diagnostics, industrial biotechnology, and agriculture, namely, custom biomanufacturing of proteins, nucleic acids, metabolites, and other biomolecules using cell-free biosynthesis systems to the order and specification of others; contract manufacturing in the field of cell-free biosynthesis; manufacturing process consulting services in the field of cell-free biosynthesis | ACTIVE | — |
| 042 | Biomedical research services in the field of cell-free biosynthesis; research and development for the pharmaceutical industry in the field of cell-free biosynthesis; pharmaceutical research and development in the field of cell-free biosynthesis; biotechnology research in the field of cell-free biosynthesis; consultancy relating to pharmaceutical research and development in the field of cell-free biosynthesis; biological research, clinical research, and medical research in the field of cell-free biosynthesis; research and development in the pharmaceutical and biotechnology fields in the field of cell-free biosynthesis; clinical research in the field of cell-free biosynthesis; medical research in the field of cell-free biosynthesis; veterinary research in the field of cell-free biosynthesis; scientific research and development in the field of cell-free biosynthesis; bacteriological research in the field of cell-free biosynthesis; provision of scientific research services in the field of cell-free biosynthesis; scientific research and development services relating to bacteriophages in the field of cell-free biosynthesis; scientific research and development in the field of microbiomes in the field of cell-free biosynthesis; scientific research and development services relating to anti-infectives in the field of cell-free biosynthesis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 10, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 10, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 4, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |